p.88 抽出テキスト

404. Lerman TT, Levi A, Kornowski R. Meta-analysis of short- and long-term clinical outcomes of the self-expanding Evolut R/pro valve versus the balloon-expandable Sapien 3 valve for transcatheter aortic valve implantation. Int J Cardiol 2023;371: 100–8. https://doi.org/10.1016/j.ijcard.2022.09.035 405. Faroux L, Chen S, Muntané-Carol G, Regueiro A, Philippon F, Sondergaard L, et al. Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis. Eur Heart J 2020;41:2771–81. https://doi.org/10.1093/eurheartj/ehz924 406. Greason KL, Lahr BD, Stulak JM, Cha YM, Rea RF, Schaff HV, et al. Long-term mortality effect of early pacemaker implantation after surgical aortic valve replacement. Ann Thorac Surg 2017;104:1259–64. https://doi.org/10.1016/j.athoracsur.2017.01.083 407. Rück A, Saleh N, Glaser N. Outcomes following permanent pacemaker implantation after transcatheter aortic valve replacement: SWEDEHEART observational study. JACC Cardiovasc Interv 2021;14:2173–81. https://doi.org/10.1016/j.jcin.2021.07.043 408. Baron SJ, Wang K, House JA, Magnuson EA, Reynolds MR, Makkar R, et al. Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at intermediate risk. Circulation 2019;139:877–88. https:// doi.org/10.1161/CIRCULATIONAHA.118.035236 409. Tam DY, Azizi PM, Fremes SE, Chikwe J, Gaudino M, Wijeysundera HC. The costeffectiveness of transcatheter aortic valve replacement in low surgical risk patients with severe aortic stenosis. Eur Heart J Qual Care Clin Outcomes 2021;7:556–63. https://doi.org/10.1093/ehjqcco/qcaa058 410. Pibarot P, Ternacle J, Jaber WA, Salaun E, Dahou A, Asch FM, et al. Structural deterioration of transcatheter versus surgical aortic valve bioprostheses in the PARTNER-2 trial. J Am Coll Cardiol 2020;76:1830–43. https://doi.org/10.1016/j.jacc.2020.08.049 411. Fatima B, Mohananey D, Khan FW, Jobanputra Y, Tummala R, Banerjee K, et al. Durability data for bioprosthetic surgical aortic valve: a systematic review. JAMA Cardiol 2019;4:71–80. https://doi.org/10.1001/jamacardio.2018.4045 412. Kedhi E, Hermanides RS, Dambrink JE, Singh SK, Ten Berg JM, van Ginkel D, et al. TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and complex or multivessel coronary disease (TCW): an international, multicentre, prospective, open-label, non-inferiority, randomised controlled trial. Lancet 2025;404: 2593–602. https://doi.org/10.1016/s0140-6736(24)02100-7 413. Martinsson A, Nielsen SJ, Milojevic M, Redfors B, Omerovic E, Tonnessen T, et al. Life expectancy after surgical aortic valve replacement. J Am Coll Cardiol 2021;78:2147–57. https://doi.org/10.1016/j.jacc.2021.09.861 414. Glaser N, Persson M, Jackson V, Holzmann MJ, Franco-Cereceda A, Sartipy U. Loss in life expectancy after surgical aortic valve replacement: SWEDEHEART study. J Am Coll Cardiol 2019;74:26–33. https://doi.org/10.1016/j.jacc.2019.04.053 415. Attinger-Toller A, Ferrari E, Tueller D, Templin C, Muller O, Nietlispach F, et al. Age-related outcomes after transcatheter aortic valve replacement: insights from the SwissTAVI registry. JACC Cardiovasc Interv 2021;14:952–60. https://doi.org/10. 1016/j.jcin.2021.01.042 416. Jørgensen TH, Thyregod HGH, Savontaus M, Willemen Y, Bleie Ø, Tang M, et al. Transcatheter aortic valve implantation in low-risk tricuspid or bicuspid aortic stenosis: the NOTION-2 trial. Eur Heart J 2024;45:3804–14. https://doi.org/10.1093/ eurheartj/ehae331 417. Dahle TG, Kaneko T, McCabe JM. Outcomes following subclavian and axillary artery access for transcatheter aortic valve replacement: Society of the Thoracic Surgeons/ American College of Cardiology TVT registry report. JACC Cardiovasc Interv 2019; 12:662–9. https://doi.org/10.1016/j.jcin.2019.01.219 418. Gleason TG, Schindler JT, Hagberg RC, Deeb GM, Adams DH, Conte JV, et al. Subclavian/axillary access for self-expanding transcatheter aortic valve replacement renders equivalent outcomes as transfemoral. Ann Thorac Surg 2018;105:477–83. https://doi.org/10.1016/j.athoracsur.2017.07.017 419. Kirker E, Korngold E, Hodson RW, Jones BM, McKay R, Cheema M, et al. Transcarotid versus subclavian/axillary access for transcatheter aortic valve replacement with SAPIEN 3. Ann Thorac Surg 2020;110:1892–7. https://doi.org/10.1016/j.athoracsur. 2020.05.141 420. Debry N, Trimech TR, Gandet T, Vincent F, Hysi I, Delhaye C, et al. Transaxillary compared with transcarotid access for TAVR: a propensity-matched comparison from a French multicentre registry. EuroIntervention 2020;16:842–9. https://doi.org/10.4244/ eij-d-20-00117 421. Beurtheret S, Karam N, Resseguier N, Houel R, Modine T, Folliguet T, et al. Femoral versus nonfemoral peripheral access for transcatheter aortic valve replacement. J Am Coll Cardiol 2019;74:2728–39. https://doi.org/10.1016/j.jacc.2019.09.054 422. Greenbaum AB, Babaliaros VC, Chen MY, Stine AM, Rogers T, O’Neill WW, et al. Transcaval access and closure for transcatheter aortic valve replacement: a prospective investigation. J Am Coll Cardiol 2017;69:511–21. https://doi.org/10.1016/j.jacc.2016. 10.024 423. Lederman RJ, Babaliaros VC, Lisko JC, Rogers T, Mahoney P, Foerst JR, et al. Transcaval versus transaxillary TAVR in contemporary practice: a propensity-weighted analysis. JACC Cardiovasc Interv 2022;15:965–75. https://doi.org/10.1016/j.jcin.2022.03.014 424. Okuno T, Asami M, Heg D, Lanz J, Praz F, Hagemeyer D, et al. Impact of left ventricular outflow tract calcification on procedural outcomes after transcatheter aortic valve replacement. JACC Cardiovasc Interv 2020;13:1789–99. https://doi.org/10.1016/j.jcin. 2020.04.015 425. Barbanti M, Yang TH, Rodès Cabau J, Tamburino C, Wood DA, Jilaihawi H, et al. Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation 2013;128: 244–53. https://doi.org/10.1161/circulationaha.113.002947 426. Kirmani BH, Jones SG, Muir A, Malaisrie SC, Chung DA, Williams RJ, et al. Limited versus full sternotomy for aortic valve replacement. Cochrane Database Syst Rev 2023;12: CD011793. https://doi.org/10.1002/14651858.CD011793.pub3 427. Paparella D, Malvindi PG, Santarpino G, Moscarelli M, Guida P, Fattouch K, et al. Full sternotomy and minimal access approaches for surgical aortic valve replacement: a multicentre propensity-matched study. Eur J Cardiothorac Surg 2020;57:709–16. https://doi.org/10.1093/ejcts/ezz286 428. Vincent F, Ternacle J, Denimal T, Shen M, Redfors B, Delhaye C, et al. Transcatheter aortic valve replacement in bicuspid aortic valve stenosis. Circulation 2021;143: 1043–61. https://doi.org/10.1161/CIRCULATIONAHA.120.048048 429. Alperi A, Voisine P, Kalavrouziotis D, Dumont E, Dagenais F, Perron J, et al. Aortic valve replacement in low-risk patients with severe aortic stenosis outside randomized trials. J Am Coll Cardiol 2021;77:111–23. https://doi.org/10.1016/j.jacc.2020.10.056 430. Makkar RR, Yoon SH, Leon MB, Chakravarty T, Rinaldi M, Shah PB, et al. Association between transcatheter aortic valve replacement for bicuspid vs tricuspid aortic stenosis and mortality or stroke. JAMA 2019;321:2193–202. https://doi.org/10.1001/jama. 2019.7108 431. Halim SA, Edwards FH, Dai D, Li Z, Mack MJ, Holmes DR, et al. Outcomes of transcatheter aortic valve replacement in patients with bicuspid aortic valve disease: a report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Circulation 2020;141:1071–9. https://doi.org/ 10.1161/CIRCULATIONAHA.119.040333 432. Forrest JK, Kaple RK, Ramlawi B, Gleason TG, Meduri CU, Yakubov SJ, et al. Transcatheter aortic valve replacement in bicuspid versus tricuspid aortic valves from the STS/ACC TVT registry. JACC Cardiovasc Interv 2020;13:1749–59. https:// doi.org/10.1016/j.jcin.2020.03.022 433. Montalto C, Sticchi A, Crimi G, Laricchia A, Khokhar AA, Giannini F, et al. Outcomes after transcatheter aortic valve replacement in bicuspid versus tricuspid anatomy: a systematic review and meta-analysis. JACC Cardiovasc Interv 2021;14:2144–55. https://doi.org/10.1016/j.jcin.2021.07.052 434. Yoon SH, Bleiziffer S, De Backer O, Delgado V, Arai T, Ziegelmueller J, et al. Outcomes in transcatheter aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis. J Am Coll Cardiol 2017;69:2579–89. https://doi.org/10.1016/j.jacc.2017.03.017 435. Jilaihawi H, Chen M, Webb J, Himbert D, Ruiz CE, Rodés-Cabau J, et al. A bicuspid aortic valve imaging classification for the TAVR era. JACC Cardiovasc Imaging 2016;9: 1145–58. https://doi.org/10.1016/j.jcmg.2015.12.022 436. Sá MPBO, Zhigalov K, Cavalcanti LRP, Escorel Neto AC, Rayol SC, Weymann A, et al. Impact of aortic annulus enlargement on the outcomes of aortic valve replacement: a meta-analysis. Semin Thorac Cardiovasc Surg 2021;33:316–25. https://doi.org/10.1053/j. semtcvs.2020.06.046 437. Head SJ, Reardon MJ, Deeb GM, Van Mieghem NM, Popma JJ, Gleason TG, et al. Computed tomography-based indexed aortic annulus size to predict prosthesispatient mismatch. Circ Cardiovasc Interv 2019;12:e007396. https://doi.org/10.1161/ circinterventions.118.007396 438. Herrmann HC, Mehran R, Blackman DJ, Bailey S, Möllmann H, Abdel-Wahab M, et al. Self-expanding or balloon-expandable TAVR in patients with a small aortic annulus. N Engl J Med 2024;390:1959–71. https://doi.org/10.1056/NEJMoa2312573 439. Yokoyama Y, Kuno T, Zaid S, Kaneko T, Takagi H, Tang GHL, et al. Surgical explantation of transcatheter aortic bioprosthesis: a systematic review and meta-analysis. JTCVS Open 2021;8:207–27. https://doi.org/10.1016/j.xjon.2021.09.023 440. Marin-Cuartas M, Tang GHL, Kiefer P, Fukuhara S, Lange R, Harrington KB, et al. Transcatheter heart valve explant with infective endocarditis-associated prosthesis failure and outcomes: the EXPLANT-TAVR international registry. Eur Heart J 2024; 45:2519–32. https://doi.org/10.1093/eurheartj/ehae292 441. Hirji SA, Percy ED, McGurk S, Malarczyk A, Harloff MT, Yazdchi F, et al. Incidence, characteristics, predictors, and outcomes of surgical explantation after transcatheter aortic valve replacement. J Am Coll Cardiol 2020;76:1848–59. https://doi.org/10.1016/ j.jacc.2020.08.048 442. Jawitz OK, Gulack BC, Grau-Sepulveda MV, Matsouaka RA, Mack MJ, Holmes DR Jr, et al. Reoperation after transcatheter aortic valve replacement: an analysis of the Society of Thoracic Surgeons database. JACC Cardiovasc Interv 2020;13:1515–25. https://doi.org/10.1016/j.jcin.2020.04.029 443. Hawkins RB, Deeb GM, Sukul D, Patel HJ, Gualano SK, Chetcuti SJ, et al. Redo surgical aortic valve replacement after prior transcatheter versus surgical aortic valve replacement. JACC Cardiovasc Interv 2023;16:942–53. https://doi.org/10.1016/j.jcin.2023.03. 015 444. Bapat VN, Zaid S, Fukuhara S, Saha S, Vitanova K, Kiefer P, et al. Surgical explantation after TAVR failure: mid-term outcomes from the EXPLANT-TAVR international Downloaded from academic.oup.com/eurheartj/article/46/44/4635/8234488 by guest on 07 October 2026